Skip to main content

BIOG-B · BioGaia AB · Financials

115.4000 SEK +1.9000 (+1.67%) At close · Oct 8
Market Cap
11.54B SEK
Shares
101.16M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Browse captured authority reports and their original financial labels

Revenue
1.1B +40.6%
FY2022 Revenue FY2020–FY2022
Net Income
373.77M +90.4%
FY2022 Net Income FY2020–FY2022
Gross Margin
72.64% -1.6pp
FY2022 Gross Margin FY2020–FY2022
Operating Margin
32.74% +0.4pp
FY2022 Operating Margin FY2020–FY2022
Operating Cash Flow
318.94M +43.7%
FY2022 Operating Cash Flow FY2020–FY2022

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2022 FY2021 FY2020
SEK 1.1B 785.11M 747.08M
SEK 302.03M 202.16M 200.16M
SEK 801.93M 582.95M 546.92M
SEK 106.81M 105.47M 104.66M
SEK 320.8M 192.44M 171.63M
SEK 39.82M 42.55M 26.13M
SEK 361.46M 253.74M 228.15M
SEK 5.39M 1.13M 722K
SEK 447.61M 252.71M 227.58M
SEK 73.84M 56.44M 47.85M
SEK 373.77M 196.27M 179.73M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2020–FY2022: 435.21M in dividends.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.